Literature DB >> 9219708

Anticytokine therapy in rheumatoid arthritis.

G S Firestein, N J Zvaifler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219708     DOI: 10.1056/NEJM199707173370310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Authors:  R John Looney
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.

Authors:  G Camussi; E Lupia
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 3.  Rheumatology.

Authors:  P Brooks
Journal:  BMJ       Date:  1998-06-13

Review 4.  PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.

Authors:  C K Edwards
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 5.  Etanercept: a review of its use in rheumatoid arthritis.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

6.  In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways.

Authors:  M M Campos; G E Souza; J B Calixto
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

7.  Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.

Authors:  J L Funk; L A Cordaro; H Wei; J B Benjamin; D E Yocum
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.

Authors:  Dawei Hu; Chunde Bao; Shunle Chen; Jieruo Gu; Zhanguo Li; Lingyun Sun; Xinghai Han; Liqing Ni
Journal:  Rheumatol Int       Date:  2008-08-15       Impact factor: 2.631

9.  Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

Authors:  D P O'Brien; D E Briles; A J Szalai; A H Tu; I Sanz; M H Nahm
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.

Authors:  Jeremy Sokolove; Reuven Bromberg; Kevin D Deane; Lauren J Lahey; Lezlie A Derber; Piyanka E Chandra; Jess D Edison; William R Gilliland; Robert J Tibshirani; Jill M Norris; V Michael Holers; William H Robinson
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.